{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:14Z","timestamp":1761102254442},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Patients with <jats:italic toggle=\"yes\">GATA2<\/jats:italic> (Emberger syndrome) deficiency needs early hematopoietic stem cell transplant (HSCT) before evolving in to myelodysplastic syndrome or acute myeloid leukemia and with time given compromised organ dysfunction leads to increase regimen-related toxicities. Most published cases have used nonmyeloablative conditioning regimens, show higher incidences of rejection and relapse rates and umbilical cord blood transplant has been reported to be suboptimal in patients with <jats:italic toggle=\"yes\">GATA2<\/jats:italic> deficiency because of longer period of engraftment leads to more infections and mortality. We report a 4.5-year-old girl with <jats:italic toggle=\"yes\">GATA2<\/jats:italic> deficiency who underwent matched unrelated donor HSCT utilizing a myeloablative conditioning regimen including intravenous busulfan (total dose of 12.8 mg\/kg) and fludarabine (total dose of 160 mg\/m<jats:sup>2<\/jats:sup>) She tolerated the conditioning regimen and bone marrow infusion well. Her initial chimerism was mixed (90% donor), cyclosporine was gradually weaned and discontinued at day+85 and this resulted in conversion to full-donor chimerism. Bone marrow assessment 3 months post-HSCT revealed normal hematopoiesis and absence of monosomy 7. At 20 months of follow-up she had full-donor chimerism with complete reconstitution of the all hematopoietic stem cells. Myeloablative matched unrelated donor HSCT represents an effective option for cure in patients with <jats:italic toggle=\"yes\">GATA2<\/jats:italic> deficiency and Emberger syndrome.<\/jats:p>","DOI":"10.1097\/mph.0000000000000737","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T15:29:39Z","timestamp":1487950179000},"page":"230-232","source":"Crossref","is-referenced-by-count":8,"title":["Successful Myeloablative Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in a Young Girl With GATA2 Deficiency and Emberger Syndrome"],"prefix":"10.1097","volume":"39","author":[{"given":"Mohammed","family":"Ramzan","sequence":"first","affiliation":[{"name":"Division of Hematology Oncology and Bone Marrow Transplantation, Hospital for Sick Children"},{"name":"University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Lowry","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology and Bone Marrow Transplantation, Hospital for Sick Children"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Courtney","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology and Bone Marrow Transplantation, Hospital for Sick Children"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Krueger","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology and Bone Marrow Transplantation, Hospital for Sick Children"},{"name":"University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Schechter Finkelstein","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology and Bone Marrow Transplantation, Hospital for Sick Children"},{"name":"University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology and Bone Marrow Transplantation, Hospital for Sick Children"},{"name":"University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2005-06-2527","article-title":"Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2","volume":"107","author":"Kitajima","year":"2006","journal-title":"Blood"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Non-myeloablative allogeneic hematopoietic stem-cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14785\/lpsn-2014-0022","article-title":"Monocytosis in a patient with a novel GATA2 mutation","volume":"2","author":"Cada","year":"2015","journal-title":"LymphoSign J"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbmt.2013.11.027","article-title":"Fludarabine and exposure-targeted busulfan compares favorably with busulfan\/cyclophosphamide based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity","volume":"20","author":"Bartelink","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.bbmt.2015.11.844","article-title":"Is busulfan and fludarabine an optimal myeloablative hematopoietic stem cell transplant (HSCT) conditioning regimen in children with AML\/MDS?","volume":"22","author":"Ramzan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/petr.12667","article-title":"Successful reduced-intensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS","volume":"20","author":"Saida","year":"2016","journal-title":"Pediatr Transplant"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","article-title":"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"208","author":"Bigley","year":"2011","journal-title":"J Exp Med"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ajmg.a.33445","article-title":"Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases","volume":"152A","author":"Mansour","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","article-title":"High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia","volume":"121","author":"Pasquet","year":"2013","journal-title":"Blood"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201704000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:04:46Z","timestamp":1695013486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201704000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000737","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}